Publications by authors named "Svigos K"

The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following procedural treatments or interventions. Research and recommendations surrounding the risk for koebnerization within scarring alopecias is extremely limited.

View Article and Find Full Text PDF
Article Synopsis
  • Social media, specifically Instagram and TikTok, has become a key source of medical information for people dealing with hair loss, prompting an analysis of popular content related to the topic.
  • The study found that a significant majority of hair loss-related posts were created by non-medical influencers (66% on Instagram and 38% on TikTok), while posts from certified medical professionals were minimal (4% on Instagram and 10% on TikTok).
  • The findings highlight the prevalence of unverified information promoting hair care products on these platforms, suggesting a critical need for dermatologists to engage with social media to educate and combat misinformation.
View Article and Find Full Text PDF

Raynaud phenomenon (RP) presents with either primary or secondary disease, and both have the potential to negatively impact patient quality of life. First-line management of RP should include lifestyle modifications in all patients. Some patients with primary RP and most with secondary RP require pharmacologic therapies, which may include calcium channel blockers, topical nitrates, phosphodiesterase 5 inhibitors, or endothelin antagonists.

View Article and Find Full Text PDF

Raynaud's phenomenon (RP) is a relatively common disease with both primary and secondary forms. It is well understood as a vasospastic condition affecting the acral and digital arteries, resulting in characteristic, well-demarcated color changes typically in the hands and feet in response to cold or stress. Secondary RP (SRP) has been described in association with a variety of rheumatologic and nonrheumatologic diseases, environmental exposures, and/or medications.

View Article and Find Full Text PDF
Article Synopsis
  • Evidence-based research on treating rare and severe skin diseases is lacking.
  • Canakinumab and anakinra are drugs that target IL-1 pathways and are increasingly used for tough-to-treat skin conditions.
  • The study aims to explore the various skin diseases that can potentially be treated with these medications.
View Article and Find Full Text PDF

Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects.

View Article and Find Full Text PDF

Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness. Due to scarring, hair loss is typically permanent.

View Article and Find Full Text PDF

Frontal fibrosing alopecia (FFA) was first described as a progressive recession of the frontal hairline in postmenopausal women. Since its initial description, recognition and understanding of FFA has expanded. The condition is now defined as a patterned, symmetric, frontotemporal scarring alopecia that is considered to be histopathologically indistinguishable from lichen planopilaris.

View Article and Find Full Text PDF